Fri, February 9, 2018

Louise Chen Initiated (SPRO) at Buy and Held Target at $27 on, Feb 9th, 2018

Louise Chen of Cantor Fitzgerald, Initiated "Spero Therapeutics, Inc." (SPRO) at Buy and Held Target at $27 on, Feb 9th, 2018.

Louise has made no other calls on SPRO in the last 4 months.



There are 3 other peers that have a rating on SPRO. Out of the 3 peers that are also analyzing SPRO, 1 agrees with Louise's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tazeen Ahmad of "B of A Securities" Initiated at Hold and Held Target at $16 on, Monday, November 27th, 2017


These are the ratings of the 2 analyists that currently disagree with Louise


  • Ritu Baral of "Cowen & Co." Initiated at Buy on, Monday, November 27th, 2017
  • Stephen Willey of "Stifel" Initiated at Strong Buy and Held Target at $26 on, Monday, November 27th, 2017